|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Retrospective analysis of topoisomerse IIa amplification and deletion as predictive markers in primary breast cancer patients randomly assigned to cyclo- phoshamide, epirubicin, and fluorouracil: Danish Breast Cancer Cooperative Group显示文摘 | Knoop AS Knudsen H Balslev E | 2005 | J Clin Oncol2005，23，： | 1 |
| 2 | Retrospective analysis of topoisomerase IIa amplifications and deletions as predictive markers in primary breast cancer patients randomly assigned to cyclophosphamide, methotrexate, and fluorouracil or cyclophospharaide, epirubicin, and fluorouracil: Danish Breast Cancer Cooperative Group显示文摘 | Knoop AS Knudsen H Balslev E | 2005 | J Clin Oncol2005，23，30： | 1 |
| 3 | Retrospectiveanalysis of topoisomerase IIa amplifications and deletionsas predictive markers in primary breast cancer patientsrandomly assigned to cyclophosphamide,methotrexate,and fluorouracil or cyclophosphamide,epirubicin,andfluorouracil:Danish Breast Cancer Cooperative Group显示文摘 | Knoop AS Knudsen H Balslev E | 2005 | J Clin Oncol2005，23，30： | 1 |
| 4 | Retrospetive analysis of topoisomerase II a amplifications and deletions as predictive mark- ers in primary breast cancer patients randomly assigned to cyclo- phosphamide, methotrexate, and fluorouracil or cyclophosphamide, epirubicin, and fluorouracil: Danish Breast Cancer Cooperative Group 显示文摘 | Knoop AS Kudsen H Balslev E | 2005 | J Clin Oneol2005，23，30： | 1 |
| 5 | The expression of receptors for estrogen and epithelial growth factor in the male rabbit prostate and prostatic urethra following castration 显示文摘 | Bodker A Balslev E Iversen H G | 1997 | Scand J Urol Nephrol1997，31，1： | 1 |
| 6 | Retrospective analysis of topoisomerase Ⅱ a amplifications and deletions as predictive markers in primary breast cancer patients randomly assigned to cyclophosphamide, methotrexate, and fluorouracil or cyclophosphamide, epirubicin, and fluorouracil: Danish Breast Cancer Cooperative Group显示文摘 | Knoop AS Knudsen H Balslev E | 2005 | J Clin Oncol2005，23，30： | 1 |
| 7 | retrospective analysis of topoisomerase ]I a amplifications and deletions as predictive markers in primary breast cancer patients randomly assigned to cyclo- phosphamide, methotrexate, and fluorouracil or cyclophosphamide, epirubicin, and fluorouracil : Danish Breast Cancer Cooperative Group 显示文摘 | Knoop AS Knudsen H Balslev E | 2005 | J Clin Oncol2005，23，30： | 1 |
| 8 | Oversto- rey control of understorey species composition in a near-natu- ral temperate broadleaved forest in Denmark显示文摘 | THOMSEN R P SVENNING J C BALSLEV H | 2005 | Plant Ecol- ogy2005，181，1： | 1 |
| 9 | Retrospective analysis of topoisomerase IIa am-plifications and deletions as predictive markers in primary breast cancer patients randomly as-signed to cyclophosphamide, methotrexate, and fluorouracil or cyclophsphamide, epirubicin, and fluorouracil: Danish Breast Cancer Cooperative Group显示文摘 | Knoop A S Knudsen H Balslev E | 2005 | J Clin Oncol2005，23，30： | 1 |
| 10 | Subcellular localization of YKL-40 in normal and malignant epithelial ceils of the breast 显示文摘 | Roslind A Balslev E Kruse H | 2008 | Uhrastruct Patho12008，32，3： | 1 |
| 11 | Susceptibility to HIV infection and progression of AIDS in relation to variant alleles of mannose-binding lectin显示文摘 | Garred P Madsen H Balslev U | 1997 | Lancet1997，349，9047： | 1 |
| 12 | Susceptibility to HIV infection and progression of AIDS in relation to vaiant alleles of mannose-binding lectin 显示文摘 | Garred P Madsen HO Balslev H | 1997 | Lancet1997，349，9047： | 1 |
| 13 | Retrospective analysis of topoisomerase II a amplifications and deletions as predictivemarkers in primary breast cancer patients randomly assigned to cyclophosphamide, methotrexate, and fluorouraeil or eyclophospha-mide, epirubicin, and fluorouraeil:Danish Breast Cancer Cooper-ative Group显示文摘 | Knoop AS Knudsen H Balslev E | 2005 | J Clin Oncol2005，23，30： | 1 |
| 14 | A dated phylogeny complements macroecological analysis to explain the diversity patterns in Geonoma (Arecaceae)显示文摘 | Roncal J Blach-Overgaard A Borchsenius F Balslev H Svenning J.C | | 0，，： | 1 |
| 15 | Ret rospective analysis of topoisomerase Ⅱa amplifications and deletions as predictive markers in primary breast cancer patients randomly assigned to cyclophosphamide,methot rexate,and fluorouracil or cyclophospha-mide,epirubicin,and fluorouracil:Danish Breast Cancer Cooper-ative Group显示文摘 | Knoop AS Knudsen H Balslev E | 2005 | J Clin Oncol2005，23，30： | 1 |
| 16 | Subcellular localization of YKL-40 in normal and malignant epithelial cells of the breast 显示文摘 | Roslind A Balslev E Kruse H | 2008 | Ultrastruct Pathol2008，32，3： | 1 |
| 17 | Retrospective analysis of topoisomerase Ⅱα amplifications and deletions as predictive markers in primary breast cancer patients randomly assigned to cyclophosphamide,methotrexate,and fluorouracil or cyclophosphamide,epirubicin,and fluorouracil:Danish Breast Cancer Cooperative Group显示文摘 | Knoop A S Knudsen H Balslev E | 2005 | J Clin Oncol2005，23，30： | 1 |
| 18 | Retrospective analysis of topoisomerase Ⅱa amplifications and deletions as predictive markers in primary breast cancer patients randomly assigned to cyclophosphamide, methotrexate, and fluorouracil or cyclophosphamide, epirubicin, and fluorouracil : Danish Breast Cancer Cooperative Group 显示文摘 | KNOOP A S KNUDSEN H BALSLEV E | 2005 | J Clin Oncol2005，23，30： | 1 |
| 19 | retrospective a- nalysis of topoisomerase Ⅱa amplifications and deletions as predic- tive markers in primary breast cancer patients randomly assigned to cyclophosphamide, methotrexate, and fluorouracil or cyclophos- phamide, epirubicin, and fluorouracil: Danish Breast Cancer Co- operative Group 显示文摘 | KNOOP A S KNUDSEN H BALSLEV E | 2005 | J Clin Oncol2005，23，30： | 1 |
| 20 | Retrospective analysis of topoisomerase IIa amplifications and deletions as predictive markers in primary breast cancer patients randomly assigned to cyclophosphamide,methotrexate,and fluorouracil or cyclophosphamide,epirubicin,and fluorouracil:Danish Breast Cancer Cooperative Group显示文摘 | Knoop AS Knudsen H Balslev E | 2005 | J Clin Oncol2005，23，30： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员